MktsMarkets

BioAtla, Inc.
NASDAQ: BCABKey statistics
BCAB News
Stories mentioning BCAB from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 4,582 | 7,995 | 9,539 | 13,684 | 12,355 | 11,650 | 16,395 | 16,198 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 9,308 | 11,255 | 13,789 | 18,647 | 17,614 | 16,244 | 22,270 | 21,972 |
| Operating Income (Loss) | (9,308) | (9,255) | (13,789) | (18,647) | (17,614) | (16,244) | (11,270) | (21,972) |
| Interest Income | 37.00 | 77.00 | 133.00 | 233.00 | 400.00 | 554.00 | 692.00 | 900.00 |
| Interest Expense | ||||||||
| Other Expense | 2,964 | (529.00) | (1,989) | (64.00) | 2,280 | 1,360 | 684.00 | 900.00 |
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (6,344) | (9,784) | (15,778) | (18,711) | (15,334) | (14,884) | (10,586) | (21,072) |
| Earnings Per Share (Basic) | (4.22) | (0.17) | (0.27) | (0.32) | (13.16) | (0.31) | (0.22) | (0.44) |
| Earnings Per Share (Diluted) | (4.22) | (0.17) | (0.27) | (0.32) | (13.16) | (0.31) | (0.22) | (0.44) |
| Weighted Average Shares Outstanding (Basic) | 1,502 | 58,828 | 58,745 | 58,504 | 1,165 | 48,573 | 48,336 | 48,215 |
| Weighted Average Shares Outstanding (Diluted) | 1,502 | 58,828 | 58,745 | 58,504 | 1,165 | 48,573 | 48,336 | 48,215 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About BCAB
BioAtla, Inc. (NASDAQ: BCAB) is a stock listed on the Nasdaq Stock Market under the ticker symbol BCAB. It last traded at $1.99 (Nov 15, 2026, 7:00 PM ET), up 27.6% on the day. That gives BioAtla a market capitalisation of $3.3M.
Over the past 52 weeks BCAB has traded between $1.07 and $71.50.
For the quarter ended Mar 31, 2026 it reported a net loss of $6.3M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$6.3M |
| Dec 31, 2025 | — | -$9.8M |
| Sep 30, 2025 | — | -$15.8M |
| Jun 30, 2025 | — | -$18.7M |
From BioAtla’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…